Abstract
1. Relationships between the plasma and urine concentrations and clearances of caffeine over successive dosage intervals at steady-state were investigated in six healthy volunteers administered caffeine, 150 mg 8 hourly for 6 days. 2. There was marked inter-individual variability in the urine (15.9-fold range) and steady-state plasma (8.1-fold range) concentrations of caffeine. 3. Urine caffeine concentrations were similar to those in plasma, with mean ratios (plasma:urine) ranging from 1.10 to 1.74. There was a good correlation (r = 0.93, P less than 0.01) between caffeine urine and plasma concentrations. 4. There was a good correlation between caffeine renal clearance and urine flow rate (r = 0.89, P less than 0.01). Caffeine renal clearance was not significantly different from the product of fu and urine flow rate, where fu is the fraction of caffeine unbound in plasma. Urine caffeine concentration and urine flow rate were not correlated (r = 0.14, P greater than 0.05). 5. The results indicate that caffeine is reabsorbed from the renal tubule to equilibrium with unbound caffeine in plasma. 6. A regulatory urine caffeine concentration limit of 12 mg 1(-1) may be exceeded by some individuals with coffee intake in the range 3 to 6 cups per day.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bonati M., Latini R., Galletti F., Young J. F., Tognoni G., Garattini S. Caffeine disposition after oral doses. Clin Pharmacol Ther. 1982 Jul;32(1):98–106. doi: 10.1038/clpt.1982.132. [DOI] [PubMed] [Google Scholar]
- Foenander T., Birkett D. J., Miners J. O., Wing L. M. The simultaneous determination of theophylline, theobromine and caffeine in plasma by high performance liquid chromatography. Clin Biochem. 1980 Jun;13(3):132–134. doi: 10.1016/s0009-9120(80)90819-x. [DOI] [PubMed] [Google Scholar]
- Gilbert R. M., Marshman J. A., Schwieder M., Berg R. Caffeine content of beverages as consumed. Can Med Assoc J. 1976 Feb 7;114(3):205–208. [PMC free article] [PubMed] [Google Scholar]
- Lelo A., Birkett D. J., Robson R. A., Miners J. O. Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man. Br J Clin Pharmacol. 1986 Aug;22(2):177–182. doi: 10.1111/j.1365-2125.1986.tb05246.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lelo A., Miners J. O., Robson R. A., Birkett D. J. Quantitative assessment of caffeine partial clearances in man. Br J Clin Pharmacol. 1986 Aug;22(2):183–186. doi: 10.1111/j.1365-2125.1986.tb05247.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lelo A., Miners J. O., Robson R., Birkett D. J. Assessment of caffeine exposure: caffeine content of beverages, caffeine intake, and plasma concentrations of methylxanthines. Clin Pharmacol Ther. 1986 Jan;39(1):54–59. doi: 10.1038/clpt.1986.10. [DOI] [PubMed] [Google Scholar]
- May D. C., Jarboe C. H., VanBakel A. B., Williams W. M. Effects of cimetidine on caffeine disposition in smokers and nonsmokers. Clin Pharmacol Ther. 1982 May;31(5):656–661. doi: 10.1038/clpt.1982.91. [DOI] [PubMed] [Google Scholar]
- Newton R., Broughton L. J., Lind M. J., Morrison P. J., Rogers H. J., Bradbrook I. D. Plasma and salivary pharmacokinetics of caffeine in man. Eur J Clin Pharmacol. 1981;21(1):45–52. doi: 10.1007/BF00609587. [DOI] [PubMed] [Google Scholar]
- Parsons W. D., Neims A. H. Effect of smoking on caffeine clearance. Clin Pharmacol Ther. 1978 Jul;24(1):40–45. doi: 10.1002/cpt197824140. [DOI] [PubMed] [Google Scholar]
- Tang-Liu D. D., Williams R. L., Riegelman S. Disposition of caffeine and its metabolites in man. J Pharmacol Exp Ther. 1983 Jan;224(1):180–185. [PubMed] [Google Scholar]